Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Dowden Nathan J Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4 Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 3,200 shares @ $18.0016, valued at $57.6k
Sold 3,897 shares @ $18.048, valued at $70.3k
04/19/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
11/02/2022 4 Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 2,100 shares @ $24.0453, valued at $50.5k
10/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2022 4 Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 1,329 shares @ $15.32, valued at $20.4k
Sold 215 shares @ $16.2477, valued at $3.5k
09/23/2022 4 Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 3,275 shares @ $15.1258, valued at $49.5k
Sold 1,018 shares @ $15.0694, valued at $15.3k
09/19/2022 4 Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 100 shares @ $15.01, valued at $1.5k
09/12/2022 4 Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 912 shares @ $15.1472, valued at $13.8k
Sold 865 shares @ $15.0646, valued at $13k
09/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2021 4 Dowden Nathan J (COO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Granted 95,148 options to buy @ $20, valued at $1.9M
10/28/2021 3 Dowden Nathan J (COO) has filed a Form 3 on Entrada Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy